![Mohammad Jad Moussa: The new EVP ‘fissure’ challenges the dichotomy of cisplatin/platinum fitness](https://oncodaily.com/pub/uploads/2024/03/Mohammad-Jad-Moussa-2-e1717843633860.jpg)
Photo from Mohammad Jad Moussa/X
Mar 7, 2024, 17:22
Mohammad Jad Moussa: The new EVP ‘fissure’ challenges the dichotomy of cisplatin/platinum fitness
Mohammad Jad Moussa, Postdoc Fellow of GU Oncology at MD Anderson Cancer Center, shared on X/Twitter:
“Our Iceberg Model in Imagining the New 1L Treatment Paradigm of metastatic urothelial cancer with Matt Campbell and Omar Alhalabi.
The new EVP ‘fissure’ challenges the dichotomy of cisplatin/platinum fitness. What lurks beneath the surface?
Emerging biomarkers and treatment strategies.”
Proceed to the article.
Source: Mohammad Jad Moussa/X